l,3-Dimethyllumazine-6,7-diamme (1) and its monomethyl -(3,4) and monophenylamino (5) derivates are interesting starting materials for the synthesis of imidazo[4,5-g] (6-22) and pyrazino[2,3-g]lumazines (23-26). Ringclosure proceeds under relative drastic conditions and the resulting reaction products are highly fluorescent. Methylation of 5,7-dimethyll-imidazo[4,5-g)lumazine (6) led to an isomeric mixture of the 1-(17) and 3-methyl derivatives (7) which could be separated chromatographically. Their structural assignment was based on unambiguous syntheses heating 4 and 3, respectively, with formamide under reflux for ringclosure. The newly synthesized compounds have been characterized by Ή-NMR and UV-spectra as well as elemental analyses.
Introduction
Condensed lumazine nngsystems ( 1 ) have so far not been investigated systematically due to the lack of appropriate precursor molecules for their s>-nthesis. Taylor et al (2) reported the synthesis of 1.3.5.tetramethyl-2-oxo-2,3-dihydro-imidazo [4,5-g] lumazine from l,3-dimethyluracil-5,6-diamine and and 4.5-diimino-l,3-dimethyl-2(3H)imidazolidinone, Rodgers et al (3 ) obtained the same type of compounds by condensing l,3-diethyl-5-nitrosouracil-4-amine with 2-thiohydantoin and Pachter et al (4) synthesized 8-amino-2,3-dihydro-6-phenyl-l//-2-imidazo [4,5-g] pteridone by Hofmann degradation. Eugster et al (5, 6) claimed that one component from Russula mushrooms, called Russupteridine-yellow I, is consistent with the 2-hydroxy-4-D-ribityl-imidazo [4,5- g]lumazine structure. The structural proof, however, condensing 6-Dribitylamino-uracil-5-amine with parabanic acid has to be doubted since the yield was only 0.7% and parabanic acid, composed of amide functions, does not show normal carbonyl reactivity (1, 3) . More reports are dealing with 2,4-dioxo-l,2,3,4-tetrahydro-pyrimido [4,5- g]-and [5,4- g]lumazmes (7, 8) often also refered as dipyrimidopyrazines. These ring-systems are, however, of no interest in the present contex and will therefore not been discussed.
Synthesis
The easy availability of l,3-dimethyllumazine-6,7-diamine (1) (9) from l,3-dimethyluracil-5,6-diamine and methyl cyanoformimidate (9) opened up a simple synthesis of 5,7-dimethyl-imidazo [4,5- g]lumazine (6) by heating the starting material in formamide under reflux for 40 min. This compound can be regarded as a pyrazine-stretched theophylline analog which has similar structural features as the benzene-stretched 5,--dimethyl-imidazo [4,5-a] benzo [4,5-d] uracil prepared by Schneller et al (10) in 1984. Methylation of 6 with CH J K,C0 3 in acetone led expectedly, to a mixture of two isomeric compounds 7 and 17 since the steric effect of the N-3 methyl group which allows a regioselective synthesis of caffeine from theophylline without formation of isocaffeine does not have any influence on the reaction at the imidazole moiety in 6. The two isomers 7 and 17 could be separated by preparative thick-layer silica-gel chromatography given almost equal amounts of the 1,5,7-(17) and 3,5,7-trimethyl -(7) derivatives. Their structural assignments could neither been achieved from Ή-NMR spectra nor from the UV-data which showed distinct differences. Unambiguous syntheses of both compounds were therefore performed from 6-methylamino-l,3-dimethyllumazine-7-amine (3) resulting Figure 1 . Chemical structures of pteridine derivates investigated from reaction of 6-chloro-l,3-dimethyllumazine-7-amine (2) (7) with methylammonium chloride in Nmethylformamide and the isomeric 7-methylamino-1.3-dimethyllumazine-6-amine (4) (8) by formamide cyclization to give 7 and 17, respectively. It is interesting to note that the two isomers differ quite strongly in their melting points by 50°C showing 350-353°C for 7 and 303-305°C for 17. In an analogous manner 1,3-dimethyl-7-phenylamino-Iumazine-6-amine (5) (8) reacted with formamide to l,3-dimethyl-3-phenylimidazo [4,5-g] lumazine (8) . Cyclization reactions of 1 could also been achieved either by heating in Ac 2 0 / pyridine to form 2,5,7-trimethyl-imidazo[4,5-g]lumazine (9) or in benzoyl chloride to afford the 5,7-dimethyl-2-phenyl analog 10. In a similar manner reacted 1 with 2-, 3-and 4-inonochloro-as well as 2.4-and 3,4-dichlorobenzoyl chloride to give 11-15 and 3 gave raise to the corresponding 1 -methyl derivatives 18-22. However, attempts to condense 1 with urea in a fusion reaction did not work but heating of both components in DMF for 30 hours under reflux gave a 61% yield of 5,7-dimethyl-2-oxo-l,2-dihydroimidazo- [4,5-gjlumazine (17) . It was furthermore possible to built up an annelated new pyrazine ring by reacting 1 with oxalyl chloride leading to l,3-dimethyl-7,8-dioxo-6,7,8,9-tetrahydropyrazino[2,3-g]lumazine (26). Analogous pyrazine-lumazine derivatives were also formed from 1 with benzil to 23, with tert.butylglyoaxal to 24 and with diethyl mesoxalate to 25 The fact that in 1 the 6-amino group is more nucleophilic then the 7-amino group the observed regioselective reaction pathway to 24 and 25, respectively,could be concluded . The same condensed pyrazino [2,3-g] pteridine ring-system has already been synthesized by Taylor et al (11) in 1959 by reacting 2,4,6,7-tetraaminopteridine with oxalic acid and leading to 2-amino-pyrazino [2,3- 
Physical Properties
In order to prove the proposed structures and to characterize the newly synthesized compounds elemental analyses, Ή-NMR-and UV-spectra were performed. In addition some pK a values were determined by the spectrophotometric method (12) to compare the basic and acidic properties of the imidazo [4,5- gjlumazines with their corresponding purine derivatives to see which différencies account upon the additional pyrazine ring.
Comparisons of the UV-spectra of the neutral Ptendmes/Vol. 13/No. 3 Figure 2 . UV-spectra of 5,7-dimethyl-imidazo[4,5-g]lumazine (6) and its 1-methyl-(17) and 3-methyl- (7) derivative.
forms of 6,7 and 17 indicate that the theophylline analog 5,7-dimethyl-imidazo[4,5-g]lumazine (6) consists in MeOH as a mixture of the two Nl-H and N3-H iautomers with the latter in preference due to a more pronounce similarity of the spectra of 6 and 7 ( Fig.l) . The prefered location of the proton at N-3 may be explained by an obvious much stronger resonance interaction of the N(1)H function with the CO group in position 8 whereas localisation at the N(3) ring atom is consistent with the fact that tautomers always prefer the least acidic combination from thermodynamical reasons. On the other hand, theophylline is almost exclusively an N7-H tautomer due to the steric effect of the N(3)-methyl group which interferes with any substituent in position 9 of the purine nucleus. The tautomeric proportion can be calculated from the basic pK a values of 7 and 8 since it is believed that the first protonation takes place at the unsubstituted N-atom of the imidazole ring leading to equivalent cations. The acidity of 6 is expectedly 1 pK a units higher then in theophylline since the π-defïcient pyrazine ring act to some extent as an electron-attracting substituent. Further analogies are observed between 5,7-dimcthyl-2-oxo-2,3-dihydroimidazo[4,5-g]lumazine (16) and 1,3-dimethyluric acid (13) . The acidities of the NH functions are quite similar in both series indicating that the first acidic pK a of 1,3-dimethyluric acid is unusually low as a result of an steric interaction of the 3-methyl group onto the peri-located proton at N-9. It is concluded from the structure of 16 that the N3-H bears the higher acidity over Nl-H due to the prefered resonance stabilization in the monoanion.
Good correlations are also found between 26 and l,3-dimethyl-6,7-dioxo-5,6,7,8-tetrahydrolumazine (14) regarding their acidic characters. The first acidic pK a of l,3-dimethyl-6,7-dioxo-5.6,7,8-tetrahydrolumazine is again very low in comparison to 26 from steric reasons of the 1-methyl group with the N8-H atom whereas 26 reveals a 2 pk a unit higher value despite the fact that the stretching middle pyrazine ring is electronically acidifying. 6-Methylamino-1,3-dimethyllumazine-7-amine (3). A mixture of 6-chloro-l,3-dimethyllumazine-7-amine (2) (7) (1.0 g, 4.14 mmol), methylaammonium chloride (2.0 g) and liquid methylamine (3 ml) was heated in N-methyl-formamide (15 ml) for 6 hours. (1 g) and methyl iodide (1 ml) in acetone (50 ml) was stirred in a closed flask for 12 h at room temp. The precipitate was collected, then stirred in ice-water (50 ml), filtered again and the solid treated with H 2 0 (30ml) and CHC1 3 (200 ml). The CHCl 3 -phase was separated, dried over Na 2 S0 4 and then evaporated to give 0.86 g of a mixture of 7 and 18. 0.1 g of the mixture was dissolved in CHC1 3 , put on a preparative silicagel plate (40x20x0.2 cm) for separation by CHCl 3 /MeOH (9:1). The slower moving band was cut out, extracted with CHC1 3 , evaporated and the residue recrystallized from DMF (4 ml) to give 0.035 g (33%) of colorless fine needles of 7 of m.p. 350-353°C. The substance is chromatographically and analytically identical with compound 7 described under a).
Experimental Part

5,7-Dimethyl-3-phenylimidazo[4,5-g]lumazine (8).
1,3-Dimethyllumazine-6-amine-7-phenylamine (5) (0.1 g, 0.34 mmol) was heated in formaide (2 ml) to 200°C for 40 min. After cooling was diluted with H 2 0 (10 ml), the precipitate collected and purified by recrystallization from DMF (5 ml . a) l,3-Dimethyllumazine-6,7-diamine (1) (9) (0.1 g, 0.45 mmol) was heated in Ac,0 (10 ml) 2 h under reflux and then evaporated. The residue was treated with cold H 2 0, neutralized by ammonia and stored in the icebox for several hours. The precipitate was collected and recrystallized from DMF 810 ml) to give 89 mg (80%) of colorless crystals of 9 of m.p. > 350°C. b) l,3-Dimethyllumazme-6,7-diamine (1) (9) (0.1 g, 0.45 mmol) was dissolved in pyridine (10 ml) by heating. Then Ac,0 ( 1 ml) was added and refluxed for 1 h. Evaporation to dryness and recrystallization of the residue from DMF gave 87 mg (79%) of colorless crystals of 9 of m.p. > 350°C. 1 H-NMR (D6-DMSO): 3.58 (s, 3H, MeN(5)); 3.35 (s, 3H, MeN(7)); 2.56 (s, 3H, MeC(2)). b) l,3-Dimethylhimazine-6,7-diamine (1) (9) (0.1 g, 0.45 mmol) was dissolved in pyridine (10 ml) by heating. Benzoyl chloride (1.5 ml) was added and then refluxed for 3 h. It was evaporated, the residue treated with EtOH, the precipitate collected and finally recrystallized from DMF (40 ml (5)); 3.87 (s, 3H, MeN (7)). l,3-Dimethyllumazine-6,7-diamine (1) (9) (0.15 g, 0.68 mmol) was dissolved in hot DMF (150 ml). Then urea (1.5 g) was added under reflux in small portions within 4 h. and the mixture heated for 30 h. On cooling a colorless precipitate separated slowly and was collected after 2 days of standing at room temp. The solid turned out to be pure and did not need further purification and gave 0.11 g (61%) of colorless crystal powder of 16 of m.p. > 350°C. Ή-NMR (D6-DMSO): 3.52 (s, 3H, MeN(5)); 3.33 (s, 3H, MeN (7)). . ,3-Dimethyllumazine-6,7-diamine (1) (9) (0.1 g, 0.45 mmol) was dissolved in pyridine (10 ml) by heating. 4-Chlorbenzoyl chloride (1.5 ml) was added and then refluxed for 3 h. It was evaporated, the residue treated with EtOH, the precipitate collected and finally recrystallized from DMF to give 115 mg (72%) l,3-Dimethyilumazme-6,7-diamine (1) (9) (0.3 g, 1.35 mmol) and benzil (3 g) were mixed thoroughly and then heated to 230-240°C for 50 min. After cooling the mixture was treated with toluene (10 ml) with stirring for 30 min. The precipitate was collected and recrystallized from EtOH (80 ml)+H 2 0 (5 ml) to give 
